Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Toxicity Testing in Animals

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...

Drug Toxicity: Dose-Dependent Reactions

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...

Drug Toxicity: Allergic Reactions

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...

Drug toxicity: Idiosyncratic Reactions

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...

Drug Toxicity: Overview

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...

Teratogenicity

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

FAVAR-GAT: A Hybrid Temporal-structural Model for Drug-target Binding Affinity Prediction.

Current drug targets·2026

Same author

Auditory dysfunction and perinatal risk factors in high-risk infants: Insights from brainstem evoked response audiometry.

Bioinformation·2026

Same author

Case report of HIV associated arthritis.

IDCases·2024

Same author

Small field measurements using electronic portal imaging device.

Biomedical physics & engineering express·2024

Same author

Emission performance evaluation of urban passenger car fleet through field investigation data in a megacity.

Environmental science and pollution research international·2024

Same author

A typology of U.S. metropolises by rent burden and its major drivers.

GeoJournal·2023

Search research articles

Related Experiment Video

Updated: May 28, 2026

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

Experimental Hepatotoxicity Produced by Ethinyl estradiol.

Govind Pandey¹, S P Pandey, Madhuri Sharma

¹Veterinary/Animal Husbandry Department, Government of MP, Jabalpur Division, NSCB Medical College, Jabalpur 482 003, India.

Toxicology International

|October 7, 2011

Summary

Ethinyl oestradiol (EO), used in contraceptives and HRT, can cause liver damage. This study shows EO induces dose- and time-dependent experimental hepatotoxicity in rats, particularly at higher doses over prolonged periods.

Keywords:

Ethinyl estradiol female albino rats hepatotoxicity histopathological study

More Related Videos

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

Related Experiment Videos

Last Updated: May 28, 2026

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

Area of Science:

Toxicology
Pharmacology
Histopathology

Background:

Ethinyl oestradiol (EO) is a widely used synthetic estrogen in oral contraceptives and hormone replacement therapy (HRT).
Excessive or prolonged exposure to EO may lead to cytotoxicity, including potential carcinogenicity in various organs.
Understanding the specific organ toxicity of EO is crucial for assessing its long-term safety profile.

Purpose of the Study:

To investigate the potential of Ethinyl oestradiol (EO) to induce experimental hepatotoxicity.
To determine the dose- and time-dependent effects of EO administration on liver tissue in a rodent model.
To characterize the histopathological changes associated with EO-induced liver injury.

Main Methods:

Female albino rats were administered varying doses of EO (250, 500, 750 μg/kg) orally, weekly, for 16 and 20 weeks.
A control group received saline.
Liver tissues were collected post-sacrifice and subjected to histopathological examination.

Main Results:

Histopathological analysis revealed significant liver damage, including congestion, hemorrhage, hepatocyte vacuolation, and sinusoidal dilation.
Degeneration and necrosis of hepatocytes were observed, characterized by increased cytoplasmic granularity and nuclear material dissolution.
Fibrosis was evident, with severity correlating positively with EO dose and duration of exposure.

Conclusions:

Ethinyl oestradiol (EO) administration causes dose- and time-dependent hepatotoxicity in female rats.
Higher doses (500 or 750 μg/kg) of EO over prolonged periods (20 weeks) are associated with significant experimental liver injury.
These findings highlight the potential for EO to induce liver damage, necessitating careful consideration of dosage and duration in clinical applications.